Project Grant R44CK000679
Award Date 9/30/25
Completion Date 9/29/27
Dollars Obligated $1M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Austin, TX, USA
Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $233,666 Project Grant to Esper Biosciences Inc. in Ithaca, NY on September 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant funding supports the development of a rapid point-of-care nucleic acid test for Hepatitis C using nanosensors. This project aligns with the CDC program's goals of controlling communicable diseases and developing innovative health technologies. The award has...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $279,270 Project Grant to Advanced Virology Inc. in Philadelphia, PA on September 30, 2025. The grant, funded through the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports the development of "LOW-COST AND HIGH EFFICIENCY DNA-BASED REVERSE GENETICS PLATFORMS FOR MANUFACTURING RNA VIRUS PRODUCTS." The project aims to advance technologies for the production of RNA virus-based products through...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $265,850 Project Grant to SKM Instruments, LLC on Sep 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant supports the development of an ULTRA-RAPID OPTICAL PLATFORM FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) OF PULMONARY NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS. The project aims to create an innovative health technology to enhance disease detection and prevention...
- The Centers for Disease Control and Prevention (CDC) awarded a $300,000 Project Grant to Pace Diagnostics, Inc. under the CDC Investigations and Technical Assistance program (CFDA 93.283). The funding will support the development of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test for the diagnosis of active TB. The project period is from Sep 30, 2025 to Mar 31, 2026. The CDC Investigations and Technical Assistance program funds research, surveillance, epidemiological...
- The Centers for Disease Control and Prevention (CDC) awarded Seacoast Science, Inc. a $541,648 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) on September 30, 2025. The purpose of this award is to develop an auto-calibrating air quality monitoring system. Seacoast Science, Inc. is a for-profit company that specializes in advanced chemical sensors, detection devices, and monitoring systems, with a focus on innovative environmental and safety monitoring...
- This $994,658 Project Grant was awarded on September 30, 2025 by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to Lo Biosciences, Inc., a minority-owned biotechnology company based in Rockville, Maryland. The award supports the development of a novel remote blood separation device for at-home plasma collection to enable HIV-1 testing. This project aims to create an innovative diagnostic technology that improves the...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $501,200 Project Grant on Sep 30, 2025 to Aptus Biosciences LLC, a minority-owned small business located in Gainesville, Florida, under the CDC's "Prevention of Disease, Disability, and Death by Infectious Diseases" program (CFDA 93.084). The funding will support the development of a rapid, affordable, aptamer-based diagnostic test for Hepatitis C virus. Aptus Biosciences specializes in advanced diagnostic research and...
- The Centers for Disease Control and Prevention (CDC) awarded a $306,469 project grant to Chromologic LLC, a minority-owned small business located in Monrovia, California, under the Investigations and Technical Assistance program (CFDA 93.283). The grant, awarded on September 30, 2025, supports the development of a Wearable Heat Related Injury Risk Analysis (WHERA) system. Chromologic specializes in advanced medical research and has secured previous grants from agencies like the National...
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop living biosensors to detect and analyze DNA at the single-base level without requiring sample purification or specialized equipment. The $565,614 award will produce a hybrid living biosensor/lateral flow assay that can rapidly detect target DNA sequences,...
- This $402,222 National Science Foundation Project Grant, funded through the Engineering program (CFDA 47.041), supports the development of a new class of simple, inexpensive, portable, and rapid molecular diagnostic platforms. The awardee, University of Cincinnati, will engineer an instrument that can reliably and quickly detect infectious diseases in human samples using a combination of biochemistry, magnetism, fluid physics, and machine learning insights. Specifically, the university will...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,047,807 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Nanohmics Inc., a small technology development company based in Austin, TX. The grant, with a performance period from September 30, 2025 to September 29, 2027, supports the development of Lateral Flow-Electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive detection of foodborne pathogens. This project aligns with the CDC program's objectives to control communicable diseases and strengthen public health capabilities through innovative health technologies.
Generated 10/21/25, 6:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.0m | 9/23/25 |